Browsing byAuthorClark, IA
Showing results 1 to 14 of 14
| Issue Date | Title | Author(s) |
| 2015-08-01 | Amyloid β: one of three danger-associated molecules that are secondary inducers of the proinflammatory cytokines that mediate Alzheimer's disease | Clark, IA; Vissel, B |
| 2021 | Broader Insights into Understanding Tumor Necrosis Factor and Neurodegenerative Disease Pathogenesis Infer New Therapeutic Approaches. | Clark, IA; Vissel, B |
| 2016-09-05 | Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agents | Clark, IA; Vissel, B |
| 2014-01-27 | Inconsistencies and Controversies Surrounding the Amyloid Hypothesis of Alzheimer's Disease | Morris, GP; Clark, IA; Vissel, B |
| 2014-03-21 | Inflammation-sleep interface in brain disease: TNF, insulin, orexin | Clark, IA; Vissel, B |
| 2018-04-19 | The inflammatory nature of post-surgical delirium predicts benefit of agents with anti-TNF effects, such as dexmedetomidine | Clark, IA; Vissel, B |
| 2017-07-01 | The meteorology of cytokine storms, and the clinical usefulness of this knowledge | Clark, IA; Vissel, B |
| 2013-10-01 | Microglia: A new frontier for synaptic plasticity, learning and memory, and neurodegenerative disease research | Morris, GP; Clark, IA; Zinn, R; Vissel, B |
| 2019-06-03 | Neurodegenerative disease treatments by direct TNF reduction, SB623 cells, maraviroc and irisin and MCC950, from an inflammatory perspective–a Commentary | Clark, IA; Vissel, B |
| 2013-04-01 | Neuroinflammation and Neuronal Loss Precede Aβ Plaque Deposition in the hAPP-J20 Mouse Model of Alzheimer's Disease | Wright, AL; Zinn, R; Hohensinn, B; Konen, LM; Beynon, SB; Tan, RP; Clark, IA; Abdipranoto, A; Vissel, B |
| 2015-01-01 | A Neurologist's Guide to TNF Biology and to the Principles behind the Therapeutic Removal of Excess TNF in Disease | Clark, IA; Vissel, B |
| 2018-10-01 | Therapeutic implications of how TNF links apolipoprotein E, phosphorylated tau, α-synuclein, amyloid-β and insulin resistance in neurodegenerative diseases | Clark, IA; Vissel, B |
| 2011-01-01 | TNF and leptin tell essentially the same story in alzheimer's disease | Clark, IA; Alleva, LM; Vissel, B |
| 2013-01-01 | Treatment implications of the altered cytokine-insulin axis in neurodegenerative disease | Clark, IA; Vissel, B |
